News, events, updates, breakthroughs. Press announcements are archived by release date, searchable by topic: Latest Press Releases - April 25, 2013
Perosphere and Daiichi Sankyo Enter into a Clinical Trial Agreement - January 31, 2013
First Hepatocellular Carcinoma Patient Ph3 Tivantinib - January 11, 2013
Top-Line Results in Phase 2 Trial in Tivantinib with Colorectal Cancer - October 25, 2012
Daiichi Sankyo Completes Enrollment in Hokusai – VTE, investigating once-daily Edoxaban in the Large - October 23, 2012
PREMIER TCT DATA / ACS-PT Patients treated with Effient and Plavix - October 02, 2012
ARQULE AND DAIICHI SANKYO ANNOUNCE DISCONTINUATION OF PHASE 3 MARQUEE CLINICAL TRIAL IN NON-SMALL CE - September 26, 2012
DJ Sustainability Asia Pacific 2012 - August 26, 2012
Daiichi Sankyo and Lilly Announce TRILOGY ACS Results Regarding Effient® (Prasugrel) in Acute Corona - June 25, 2012
Plant FDA Approval to Package Product at New Facility in Bethlehem, PA - June 02, 2012
Tivantinib Positive Phase 2 Study Results - ASCO 2012 - May 18, 2012
Completion of Patient Recruitment in Phase 3 Clinical Trial of Tivantinib - May 17, 2012
Positive Phase 2 Clinical Data With Tivantinib in Hepatocellular Carcinoma to be Highlighted in Oral | |
